CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to CELG-RI

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Apr '27
CELG-RIPhase 3

Iberdomide Phase 3 Est. Readout

Iberdomide
Apr 2027~
CT.gov
00%
Feb '27
CELG-RIPDUFA
Phase 3Approved

FDA PDUFA Date iberdomide

Iberdomide
Feb 2027~
Source
Drug Information

Target Indication

Multiple Myeloma

Clinical Trial

NCT05827016

Last updated: 2/18/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.